Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
All research applications are conducted in controlled laboratory settings using animal or in vitro models
An analysis of six clinical trials found that AOD 9604 had a safety profile comparable to placebo and did not act through the IGF-1 pathway
1 Remove GLOW Blend vial from refrigeration and allow to reach room temperature (1520 minutes) 2 Clean vial top with alcohol swab and allow to air dry completely 3 Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water) 4 Inject BAC water slowly down the side of the vial do not aim directly at the powder 5 Gently swirl in circular motions DO NOT shake vigorously as this degrades the peptide 6 Allow 23 minutes for full dissolution solution should be clear and colorless 7 Draw calculated dose into an insulin syringe for subcutaneous injection 8 Inject into abdomen, thigh, or upper arm
To maintain optimal stability, keep the pen away from light, and do not expose it to repeated temperature changes
Nitric-oxide (NO) and eNOS activity in vascular-research models using BPC-157
US$ 22.27
US$ 25.24
US$ 28.48
US$ 24.01
US$ 21.50
